Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Summary: Antiretroviral therapy (ART) is a life‐saving intervention in human immunodeficiency virus (HIV) infection. Immune restoration after ART dramatically reduces the incidence and severity of opportunistic diseases and death. On some occasions, immune restoration may be erratic, leading to acute inflammatory responses (known as immune reconstitution inflammatory syndrome) shortly after ART initiation, or incomplete, with residual inflammation despite chronic treatment, leading to non‐infectious morbidity and mortality. We propose that ART may not always restore the perfect balance of innate and adaptive immunity in strategic milieus, predisposing HIV‐infected persons to complications of acute or chronic inflammation. The best current strategy for fully successful immune restoration is early antiretroviral therapy, which can prevent acquired immunodeficiency syndrome (AIDS)‐associated events, restrict cell subset imbalances and dysfunction, while preserving structural integrity of lymphoid tissues. Future HIV research should capitalize on innovative techniques and move beyond the static study of T‐cell subsets in peripheral blood or isolated tissues. Improved targeted therapeutic strategies could stem from a better understanding of how HIV perturbs the environmental niches and the mobility and trafficking of cells that affect the dynamic cell‐to‐cell interactions and determine the outcome of innate and adaptive immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · cited 1×
“Finally, it remains unclear how depletion and subsequent recovery with ART of T-memory stem cells, a recently described T-cell subset with robust proliferative and functional potential (99), may be affecting T-cell restoration in HIV.”
BackgroundAutran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785 · cited 3×
“Initiating combination antiretroviral therapy (ART) can achieve suppression of viral replication and an increase in CD4 T-cell counts in the majority of patients (1), resulting in dramatic decreases in morbidity and AIDS-related mortality (2).”
Background. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir627 · Cited by 1,331 · cited 2×
“Strikingly, even those with recovery of near-normal CD4 T-cell counts may maintain chronic immune activation that has been linked to an increased risk of non-AIDS-related morbidity and mortality (7, 8), making it clear that the detrimental effects of HIV infection go beyond CD4 T-cell depletion and immunodeficiency.”
BackgroundMehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146 · cited 1×
“Although treatment with ART can produce a remarkable restoration of peripheral CD4 T cells, reduce CD4 T-cell activation, and improve CD4 T-cell populations at effector sites (51), some reports showed that restoration of CD4 T cells in the lamina propria may be incomplete, even after up to 5 years on ART (83).”
BackgroundMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127 · cited 1×
“Other immunomodulating drugs, particularly those with anti-inflammatory activity including methotrexate, shown to reduce cardiovascular events in patients with rheumatoid arthritis (130), and statins (131) continue to be investigated, and as we have shown, studies should predominantly focus on targets related to innat…”
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011 · cited 1×
“A recent publication described 14 patients from the Virological and Immunological Studies in CONtrollers after Treatment Interruption (VISCONTI) cohort, who, after beginning therapy during acute HIV infection, went on to spontaneously control viral replication once treatment was interrupted (114).”
Greub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Burgisser, P., Erb, P., Boggian, K., Piffaretti, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03232-3 · Cited by 894 · cited 1×
“Some of the risk factors for a limited CD4 T-cell recovery include older age (40), lower CD4 T-cell nadir prior to ART (41), and active co-infection, most notably with hepatitis C virus (42, 43), but the strongest predictor remains a lower nadir CD4 T-cell count before ART initiation.”
Background
Cited by
(2020) · doi:10.1016/s2214-109x(20)30264-3 · Cited by 1,190
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo
Simonetti, F. R., Sobolewski, M. D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E. M., Watters, S. A., Hill, S., Wu, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522675113 · Cited by 372
Vujkovic-Cvijin, I., Sortino, O., Verheij, E., Sklar, J., Wit, F. W., Kootstra, N. A., Sellers, B., Brenchley, J. M., Ananworanich, J., Loeff, M. S. V. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16222-8 · Cited by 196
“Comorbidities objectively assessed during each study visit were: (1) chronic obstructive pulmonary disease (COPD) (GOLD 2 or more by spirometry); (2) advanced liver fibrosis (FIB-4 ≥ 3.”
MethodSelf-citationSiderophores: More than Stealing Iron
Behnsen, J., & Raffatellu, M. (2016) · mBio · doi:10.1128/mbio.01906-16 · Cited by 79
Metadata
- Authors
- Wilson, E. M. P., & Sereti, I.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2013-06-16
- Volume
- 254
- Issue
- 1
- Pages
- 343-354
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2087450881
- Cited by
- 167
- References
- 123
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.